The Department of Health and Family Welfare vide notification dated the 13th January, 2022 has issued the New Drugs and Clinical Trials (Amendment) Rules, 2022. The amendment has extended the scope of new drugs to include cell or stem cell derived product. Previously the definition of new drug under the New Drugs and Clinical Trials Rules only included stem cell derived product.
The Central Drugs Standard Control Organization (CDSCO) has announced the relocation of its Sub-Zonal Office in Uttarakhand. All official submissions and communications should now be
The B.Sc.(N) program session will commence on August 1, 2025, with a last date for admissions set for September 30, 2025. The entrance exam for
Drafts of the revised classification lists are available for public review. Stakeholders, including industry associations and medical professionals, are encouraged to provide feedback through the
The 8th edition of NPOP positions India to become a leading global exporter of organic products. By fostering a supportive ecosystem and strengthening organic certification,
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
